Sign in
av/progenity--big.svg

NASDAQ:PROG

Biora Therapeutics, Inc.

  • Stock

USD

Last Close

0.92

09/05 04:00

Market Cap

8.18M

Beta: -

Volume Today

2.78M

Avg: 6.37M

PE Ratio

−0.11

PFCF: −0.53

OverviewFinancialsFilingspeopleOwnershipAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Excel Tearsheet
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
1.10
-
1.42
28.74%
0.48
66.00%
0.01
97.62%
0.01
50.27%
0.00
97.75%
cash conversion cycle
9.68
-
40.36
316.93%
42.01
4.09%
cash per share
64.17
-
23.56
63.29%
83.67
255.14%
22.98
72.53%
3.99
82.63%
0.96
75.85%
company equity multiplier
-3.15
-
-1.21
61.48%
-1.44
19.01%
-1.28
11.27%
-0.52
59.14%
-0.31
41.18%
days of inventory outstanding
30.19
-
39.72
31.58%
47.73
20.16%
days of payables outstanding
43.74
-
57.22
30.81%
68.01
18.86%
days of sales outstanding
23.23
-
57.86
149.02%
62.29
7.66%
191.13
206.85%
990.89
418.42%
75.74K
7,543.42%
dividend yield
0.01
-
ebit per revenue
-0.89
-
-0.97
9.02%
-2.63
169.90%
-94.50
3,497.72%
-202.56
114.36%
-16.79K
8,186.78%
ebt per ebit
1.08
-
1.06
2.09%
1.18
11.03%
1.52
28.62%
0.80
47.42%
1.85
132.46%
effective tax rate
-0.04
-
0.00
111.20%
0.16
3,337.10%
0.00
99.59%
0.01
1,180.19%
0.00
91.52%
enterprise value multiple
-3.47
-
-3.76
8.17%
-1.11
70.50%
-3.75
238.60%
-2.07
44.82%
-0.77
62.63%
fixed asset turnover
8.34
-
9.06
8.60%
4.17
54.03%
0.31
92.54%
0.10
68.71%
0.00
98.52%
free cash flow per share
-64.87
-
-78.32
20.74%
-155.10
98.03%
-43.77
71.78%
-8.54
80.49%
-3.08
63.92%
gross profit margin
0.28
-
0.30
7.68%
-0.26
185.18%
1
488.67%
1
0%
1
0%
interest coverage
-12.57
-
-15.23
21.21%
-5.60
63.25%
9.33
266.61%
-5.62
160.28%
-6.84
21.69%
inventory turnover
12.09
-
9.19
24.00%
7.65
16.78%
long term debt to capitalization
2.07
-
-6.31
404.94%
2.95
146.80%
3.05
3.28%
5.01
64.08%
-0.76
115.14%
net income per ebt
1.04
-
1.00
4.52%
0.84
15.91%
1.00
19.41%
0.99
0.79%
1.00
0.61%
net profit margin
-1.01
-
-1.03
1.91%
-2.59
151.99%
-143.16
5,425.78%
-160.10
11.83%
-31.03K
19,281.05%
operating cash flow per share
-60.39
-
-75.67
25.30%
-150.61
99.04%
-43.55
71.09%
-8.44
80.63%
-3.07
63.56%
operating cycle
53.42
-
97.58
82.65%
110.02
12.75%
operating profit margin
-0.89
-
-0.97
9.02%
-2.63
169.90%
-94.50
3,497.72%
-202.56
114.36%
-16.79K
8,186.78%
payables turnover
8.34
-
6.38
23.55%
5.37
15.87%
pretax profit margin
-0.97
-
-1.03
6.74%
-3.10
199.68%
-143.26
4,527.39%
-161.48
12.72%
-31.11K
19,163.61%
price fair value
-9.57
-
-5.48
42.68%
-1.37
75.10%
-2.36
73.20%
-0.25
89.58%
-0.21
14.76%
receivables turnover
15.71
-
6.31
59.84%
5.86
7.12%
1.91
67.41%
0.37
80.71%
0.00
98.69%
return on assets
-1.11
-
-1.46
31.20%
-1.25
14.34%
-1.64
31.57%
-0.91
44.38%
-3.98
335.84%
return on capital employed
-2.98
-
-100.81
3,283.14%
-2.39
97.63%
-2.49
4.52%
-2.04
18.06%
2.11
203.42%
return on equity
3.49
-
1.76
49.46%
1.80
1.95%
2.10
16.75%
0.48
77.28%
1.22
156.35%
total debt to capitalization
2.03
-
-6.99
443.60%
2.93
141.99%
3.05
3.99%
4.87
59.68%
-0.82
116.84%

All numbers in USD (except ratios and percentages)